The results of clinical studies but also statistics on hypertension and even more important statistics on pharmacological treatment of hypertension in COVID-19 patients may shed light on the discussions if treatment with ACE inhibitors and angiotensin receptor blockers (ARBs) are detrimental52 or beneficial53. This evidence concerns the gene ACE and hypertensive disorder.